1 in 8 Adults Currently Report Taking a GLP-1 Drug for Weight Loss, Diabetes or Other Condition, Even as Half Say the Drugs Are Difficult to Afford
About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds. Few adults think it is likely their prescription costs will go down as a result of recently announced Trump administration policies. Read the news release →